These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38444060)

  • 21. Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.
    Rahhal RM; Bishop WP
    Inflamm Bowel Dis; 2008 Dec; 14(12):1678-82. PubMed ID: 18521913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
    van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
    Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis.
    Chebli LA; Chaves LD; Pimentel FF; Guerra DM; Barros RM; Gaburri PD; Zanini A; Chebli JM
    Inflamm Bowel Dis; 2010 Apr; 16(4):613-9. PubMed ID: 19705415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiopurines with low-dose allopurinol (ThiLDA)-a prospective clinical one-way crossover trial.
    Chavoushi SF; Jharap B; Friedrich P; Smid K; Peters GJ; Malingré M
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1669-1674. PubMed ID: 31587102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Meijer B; Seinen ML; van Egmond R; Bouma G; Mulder CJJ; van Bodegraven AA; de Boer NKH
    Inflamm Bowel Dis; 2017 Nov; 23(11):2011-2017. PubMed ID: 28617756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiopurine Optimization Through Combination With Allopurinol in Children With Inflammatory Bowel Diseases.
    Serpico MR; Maltz R; Crandall W; Bricker J; Dotson JL; Kim SC; Boyle B
    J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):341-345. PubMed ID: 29601433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource.
    Stournaras E; Qian W; Pappas A; Hong YY; Shawky R; ; Raine T; Parkes M;
    Gut; 2021 Apr; 70(4):677-686. PubMed ID: 33004550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol: a useful adjunct to thiopurine therapy for pediatric ulcerative colitis in the biologic era.
    Ihekweazu FD; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):22-4. PubMed ID: 24590210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-term efficacy of azathioprine in steroid-dependent ulcerative colitis.
    Park SK; Yang SK; Ye BD; Kim KJ; Yang DH; Jung KW; Park SH; Kim JW; Byeon JS; Myung SJ; Kim JH
    Scand J Gastroenterol; 2013 Dec; 48(12):1386-93. PubMed ID: 24164382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
    Kennedy NA; Kalla R; Warner B; Gambles CJ; Musy R; Reynolds S; Dattani R; Nayee H; Felwick R; Harris R; Marriott S; Senanayake SM; Lamb CA; Al-Hilou H; Gaya DR; Irving PM; Mansfield J; Parkes M; Ahmad T; Cummings JR; Arnott ID; Satsangi J; Lobo AJ; Smith M; Lindsay JO; Lees CW
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1313-23. PubMed ID: 25284134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Thiopurine Treatment Failure in Biologic-Naïve Ulcerative Colitis Patients.
    Thapa SD; Hadid H; Usman M; Imam W; Hassan A; Schairer J; Jafri SM; Kaur N
    Dig Dis Sci; 2016 Jan; 61(1):230-7. PubMed ID: 26511478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.
    Park MS; Kim DH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Dis Sci; 2015 Jan; 60(1):195-204. PubMed ID: 25239495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Prieux-Klotz C; Nahon S; Amiot A; Sinayoko L; Galéano-Cassaz C; Chaussade S; Coriat R; Lahmek P; Abitbol V
    Dig Dis Sci; 2017 Feb; 62(2):473-480. PubMed ID: 27853898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of long-term thiopurine maintenance treatment for ulcerative colitis in Turkey: A single-center experience.
    Özgenç F; Karakoyun M; Ecevit Ç; Hekimci H; Kıran Taşçı E; Erdemir G
    Turk J Gastroenterol; 2018 Nov; 29(6):650-654. PubMed ID: 30381272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study.
    Mallet AL; Bouguen G; Conroy G; Roblin X; Delobel JB; Bretagne JF; Siproudhis L; Peyrin-Biroulet L
    Dig Liver Dis; 2017 Mar; 49(3):280-285. PubMed ID: 28089625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
    Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
    Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
    Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.